Presentation EuroPCR 2024 Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes Presenter: Alexandre Abizaid May 14, 2024
News Conference News EuroPCR 2023 ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure Todd Neale May 18, 2023
News Conference News EuroPCR 2022 Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO Yael L. Maxwell May 23, 2022
News Conference News EuroPCR 2019 Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry Caitlin E. Cox May 31, 2019
News Conference News EuroPCR 2019 New Clarity on Patients at High Risk for Bleeding After PCI Michael O'Riordan May 28, 2019
News Conference News EuroPCR 2019 TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement Shelley Wood May 23, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Conference News EuroPCR 2017 The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone Yael L. Maxwell May 17, 2017
News Conference News EuroPCR 2016 EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy Yael L. Maxwell May 17, 2016
News Conference News EuroPCR 2014 EuroPCR Features PAD Therapies in Early Development and Real-World Use Caitlin E. Cox May 21, 2014